Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classification.
Deng MY, Hinz F, Maas SLN, Anil G, Sievers P, Conde-Lopez C, Lischalk J, Rauh S, Eichkorn T, Regnery S, Bauer L, Held T, Meixner E, Lang K, Hörner-Rieber J, Herfarth K, Jones D, Pfister SM, Jungk C, Unterberg A, Wick W, von Deimling A, Debus J, Sahm F, König L.
Deng MY, et al. Among authors: lischalk j.
Neurooncol Adv. 2023 May 14;5(1):vdad059. doi: 10.1093/noajnl/vdad059. eCollection 2023 Jan-Dec.
Neurooncol Adv. 2023.
PMID: 37293256
Free PMC article.